AVN-944
AVN-944 (VX-944) is an orally active, potent, selective, noncompetitive and specific inhibitor of IMPDH (inosine monophosphate dehydrogenase) . AVN-944 is an essential rate-limiting enzyme in de novo guanine nucleotide synthesis. AVN-944 is also an inhibitor of arenavirus RNA synthesis, and blocks arenavirus infection. AVN-944 has broad anti-cancer activities, and can be used for multiple myeloma (MM) and acute myeloid leukemia (AML) research[1][2][3].
Product Specifications
CAS Number
297730-17-7
Product Name Alternative
VX-944
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; Arenavirus; Bcl-2 Family; Caspase; DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Anti-infection; Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/AVN-944.html
Purity
99.89
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O[C@@H](CC#N)CC)N[C@H](C1=CC=CC(NC(NC2=CC=C(C3=CN=CO3)C(OC)=C2)=O)=C1)C
Molecular Formula
C25H27N5O5
Molecular Weight
477.51
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
Bak; Bax; Caspase 3; Caspase 8; Caspase 9
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse C-X-C chemokine receptor type 6, Cxcr6 ELISA KIT
Reagecon Colour Reference Solution No.4 Orange Yellow according to Chinese Pharmacopoeia (ChP)
Human Myeloid leukemia factor 1 (mLF1) (NM_001195432) AAV Particle
